Bio-Rad trades at nearly 30 times forward earnings despite recent losses, reflecting expectations for a turnaround as its projected EPS growth exceeds 115%. Thursday’s results will test whether that ...

Documents show Reedley biolab operator Jia Bei Zhu has a criminal history, close ties to China's government, and entered the ...

Dive into a step-by-step journey as we craft a detailed miniature diorama of a mad scientist's lab, where a werewolf ...

Capcom and biotech art group LOM BABY bring Resident Evil’s T-virus to Shibuya PARCO, explaining the exhibit, safety claims, and real biotech context ...

Make time for The Curious Incident of the Dog in the Night-Time on the Waltham Patch calendar ...

A new study from Caltech explores the remarkable way a SoCal beetle infiltrates the colonies of the ant that runs the show in ...

AI promises to fix dating apps’ swipe fatigue and first-message dread. It may just turn love into something smoother, safer — ...

A social media post cited by Elon Musk to bolster his argument that mail-in voting should be curtailed, and which was subsequently amplified by President Donald Trump, makes the false and long-ago ...

About Seer Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph™ Product Suite is an integrated solution that includes ...

From fundamental biological units as tiny as genes to complex societies, ecological systems rely on cooperation. All manner ...

Royalty Pharma’s valuation remains attractive, supported by sector momentum and sustained capital returns. Click here to know ...